Eli Lilly CEO: Alzheimer’s drug trial shows slowed disease progression by 40-60% in early patients YouTube Eli Lilly (LLY) 2 months
Obesity treatment optimism boosts Eli Lilly, Novo Nordisk while others face downturn Investing.com 5 days
Eli Lilly: A Potential Game Changer For Weight Management And Cardiovascular Health Seeking Alpha 2 weeks
Eli Lilly and Company (LLY) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript) Seeking Alpha 2 weeks
Weight-Loss Drug Market Can Hit $100 Billion, J.P. Morgan Says. That Makes Eli Lilly Stock a Big Winner. Yahoo Finance 3 weeks
Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad? Seeking Alpha 1 month
Eli Lilly’s strong Q2 market cap growth driven by diabetes drug Mounjaro – GlobalData Investing.com 1 month
Why This Nugget Of Bad Weight-Loss News Isn’t Weighing On Lilly, Novo Investor's Business Daily 1 month
The Score: Eli Lilly, WeWork, Walt Disney and More Stocks That Defined the Week The Wall Street Journal 2 months
Barclays: Novo Nordisk and Eli Lilly have first-move advantage in the obesity drug race YouTube 2 months
